AbbVie-Backed Startup Raises $133 Million To Fight Alzheimer’s With Immunotherapy – Forbes

ForbesWith backing from some of biotech’s biggest players, a startup taking on Alzheimer’s disease announced Wednesday that it’s raised $133 million in a Series E funding round. Alector, based in South San Francisco, California, is focused on developing … and more …read more Source:: Startup Tech News From Google News

from WordPress https://ift.tt/2mHccY8
via IFTTT

Newer Post Older Post